TC Biopharm (TCBPW) News Today $0.01 0.00 (0.00%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period TC Biopharm awarded funding of $250,000 from G-Rex Grant ProgramNovember 13 at 12:59 AM | markets.businessinsider.comTC BioPharm Isn't at Risk of Delisting, Company SaysOctober 25, 2024 | marketwatch.comTC BioPharm Refutes Rumors Of Delisting From Nasdaq, Confirms Compliance With Nasdaq RequirementsOctober 25, 2024 | markets.businessinsider.comBioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) Announces Newly Opened London-Based ACHIEVE UK Trial Site Amid ‘Very Positive’ Study ProgressionSeptember 25, 2024 | msn.comInvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Marks Milestone as First Patient Completes Full Dose in ACHIEVE Trial with No Adverse EventsSeptember 12, 2024 | msn.comTC BioPharm: TCBP Announces Plan to Implement ADS Ratio ChangeAugust 3, 2024 | finanznachrichten.deTC BioPharm adjusts ADS to ordinary share ratioAugust 3, 2024 | investing.comLatest News for TC BioPharm (Holdings) Stock (NASDAQ:TCBP)May 7, 2024 | benzinga.comTC BioPharm regains compliance with NasdaqJanuary 4, 2024 | msn.comTC BioPharm Shares Drop After Half of Workforce Gets CutJanuary 3, 2024 | marketwatch.comTC BioPharm Announces Additional Cost Reduction Steps to Improve Financial Standing and Streamline EfficienciesJanuary 3, 2024 | finance.yahoo.comTC BioPharm Shares Tumble After Offering Gets PricedDecember 19, 2023 | marketwatch.comTrading was temporarily halted for "TCBPW" at 07:12 PM with a stated reason of "News pending."December 15, 2023 | marketbeat.comTC Biopharm plans to implement ADS ratio changeDecember 13, 2023 | msn.comTC BioPharm Announces Plan to Implement ADS Ratio ChangeDecember 13, 2023 | finance.yahoo.comTC BioPharm receives FDA approval for AML cell therapy trialNovember 28, 2023 | msn.comTC BioPharm Inks Trial-Management Deal With Fortrea Amid Cost CuttingNovember 2, 2023 | marketwatch.comTC BioPharm Announces Streamlined Efficiencies and Reduces Overhead with Selection of Single Global CRO for Clinical TrialsNovember 2, 2023 | finance.yahoo.comADRs End Higher; TC Biopharm PLC Climbs 19%October 30, 2023 | morningstar.comTC BioPharm Selects Excellos as CDMO in Anticipation of Expanded US Clinical Trial RequirementsOctober 25, 2023 | finance.yahoo.comTC BioPharm Announces Filing Of IND For TCB-008 - Quick FactsOctober 23, 2023 | markets.businessinsider.comTC BioPharm Announces Submission of Investigational New Drug (IND) Application to U.S. FDA for Treatment of Relapse/Refractory AMLOctober 23, 2023 | finance.yahoo.comTC Biopharm (Holdings) Plc (TCBPW)October 12, 2023 | finance.yahoo.comTC BioPharm to Present at the LD Micro Main Event XVISeptember 27, 2023 | finance.yahoo.comTC BioPharm Maintains Nasdaq ListingJuly 31, 2023 | finance.yahoo.comTC BioPharm CEO, Bryan Kobel, is Featured on The Stock Day PodcastJuly 6, 2023 | finance.yahoo.comTC BioPharm to Present at LD Micro Invitational XIII Conference on June 7, 2023May 24, 2023 | finance.yahoo.comTC BioPharm Announces Closing of $5.5 Million Public OfferingMarch 30, 2023 | finance.yahoo.comADRs End Higher, Ambev and TC BioPharm Trade HigherMarch 28, 2023 | morningstar.comTC BioPharm Announces Pricing of $5.5 Million Public OfferingMarch 28, 2023 | finance.yahoo.comTC BioPharm Unveils Corporate Restructuring Plan; To Cut Up To 30% Of WorkforceMarch 22, 2023 | markets.businessinsider.comTC Biopharm Announces Corporate Restructuring, Reduction in OverheadMarch 22, 2023 | finance.yahoo.comTC BioPharm Shifts Focus to FDA Clinical TrialsMarch 7, 2023 | finance.yahoo.comTC BioPharm Announces Dr. Mike Leek as Chief Technology OfficerFebruary 23, 2023 | finance.yahoo.comTC BioPharm Announces Publication of Paper in AML Research Highlighting the Company's Development of Allogeneic Gamma-Delta T cell TherapiesFebruary 21, 2023 | finance.yahoo.comTC BioPharm Announces New Chair of the Board, Arlene MorrisFebruary 14, 2023 | finance.yahoo.comTC BioPharm Announces Successful Dosing of Final Patient in ACHIEVE Safety CohortFebruary 7, 2023 | finance.yahoo.comTC BioPharm Announces Hiring of Chief Clinical Officer Bree Harlin to Lead Global Clinical DivisionJanuary 30, 2023 | finance.yahoo.comTC Biopharm Shares Drop 13% After Nasdaq Non-Compliance NoticeJanuary 20, 2023 | marketwatch.comTC BioPharm to Host Shareholder Update CallJanuary 20, 2023 | finance.yahoo.comFinancialnewsmedia.com: Initiatives For Development of Gamma Delta T Cell Therapies Driven by Large Number of Clinical TrialsJanuary 19, 2023 | finanznachrichten.deTC BioPharm Receives Notice of Non-compliance with NASDAQ's Listing Rule 5550(b)(1)January 19, 2023 | finance.yahoo.comTC BioPharm Announces Closing of $7.35 Million Private PlacementNovember 30, 2022 | finance.yahoo.comTC BioPharm Begins Dosing Phase 2B Clinical Study Evaluating its Lead Compound, OmnImmune®, in Patients with Acute Myeloid LeukemiaNovember 22, 2022 | finance.yahoo.comTC BioPharm to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceAugust 22, 2022 | finance.yahoo.comTC Biopharm Announces Closing of $4 Million Underwritten Public OfferingJune 7, 2022 | finance.yahoo.comKuick Research Recognizes TC BioPharm as a Key Player in the Gamma-Delta T Cell Therapy MarketMay 23, 2022 | finance.yahoo.comTC BioPharm Announces Formation of Scientific Advisory Board with Renowned Cell Therapy ExpertsMay 18, 2022 | finance.yahoo.com Get TC Biopharm News Delivered to You Automatically Sign up to receive the latest news and ratings for TCBPW and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking footage from Bill Gates’ $100,000,000,000 AI Bet (Ad)If you missed out on Nvidia, watch this BEFORE November 19th. Click here for the full video TCBPW Media Mentions By Week TCBPW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TCBPW News Sentiment▼1.580.54▲Average Medical News Sentiment TCBPW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TCBPW Articles This Week▼20▲TCBPW Articles Average Week Get TC Biopharm News Delivered to You Automatically Sign up to receive the latest news and ratings for TCBPW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alvotech News Today biote News Today BriaCell Therapeutics News Today Clever Leaves News Today Fortress Biotech News Today GeoVax Labs News Today LAVA Therapeutics News Today Mainz Biomed News Today Pharvaris News Today Procaps Group News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TCBPW) was last updated on 11/16/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this BEFORE November 19th.Brownstone Research | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TC Biopharm (Holdings) Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share TC Biopharm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TCBPW Stock Alerts